The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year. At the World Economic Forum, on Tuesday (January 21), the CEO Demis Hassabis spoke on a panel which discussed the use of AI in propelling scientific progress across fields. It was there that he said work is ongoing to try and design drugs with the use of artificial intelligence.